Arvinas (ARVN) Total Debt (2017 - 2026)
Arvinas' (ARVN) quarterly Total Debt came in at $500000.0 in Q1 2026, down 28.57% year-on-year from $700000.0 in Q1 2025, and up 25.0% quarter-over-quarter from $400000.0 in Q4 2025.
Arvinas (ARVN) Total Debt (2017 - 2026) Analysis & Trends
Arvinas' Total Debt history runs 10 years deep, the most recent figure standing at $500000.0 for Q1 2026.
- On a quarterly basis, Total Debt fell 28.57% year-over-year to $500000.0 in Q1 2026; TTM through Mar 2026 was $500000.0, a 28.57% decrease from a year earlier, with the FY2025 full-year figure at $400000.0, down 50.0% from the prior year.
- Total Debt grew to $500000.0 in Q1 2026 per ARVN's latest filing, from $400000.0 in the prior quarter.
- Across five years, Total Debt topped out at $1.2 million in Q3 2023 and bottomed at $400000.0 in Q4 2025.
- The 5-year median for Total Debt is $800000.0 (2023), against an average of $811764.7.
- Across the five-year window, Total Debt sank 50.0% in 2022 and grew 20.0% in 2023, its largest moves.
- Year by year, Total Debt stood at $1.0 million in 2022, then dropped by 20.0% to $800000.0 in 2023, then changed by 0.0% to $800000.0 in 2024, then sank by 50.0% to $400000.0 in 2025, then grew by 25.0% to $500000.0 in 2026.
- Per Business Quant, the three latest ARVN Total Debt figures stand at $500000.0 (Q1 2026), $400000.0 (Q4 2025), and $600000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 110.96 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 959.06 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Arvinas | 512.64 Mn | -102.26 Mn | - | 500,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Dec 31, 2024 | 800,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 700,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Sep 30, 2023 | 1.20 Mn |
| Jun 30, 2023 | 1.00 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 1.00 Mn |
| Jun 30, 2021 | 1.00 Mn |